ArticleslgStudy

biology

Pariglasgene brecaparvovec

Pariglasgene brecaparvovec is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Pariglasgene brecaparvovec rather than just read about it. In short: Pariglasgene brecaparvovec, sold under the brand name Genglycos, is a gene therapy medication used for the treatment of glycogen storage disease type Ia. Pariglasgene brecaparvovec is an adeno-associated virus vector-based gene therapy.

Key takeaways

  • Pariglasgene brecaparvovec belongs to biology; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Pariglasgene brecaparvovec to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Pariglasgene brecaparvovec from memory before moving on to harder problems.

Reference excerpt

Pariglasgene brecaparvovec, sold under the brand name Genglycos, is a gene therapy medication used for the treatment of glycogen storage disease type Ia. Pariglasgene brecaparvovec is an adeno-associated virus vector-based gene therapy. It is given via intravenous infusion. Pariglasgene brecaparvovec was approved for medical use in the United States in August 2026.

Medical uses Pariglasgene brecaparvovec is indicated to reduce daily cornstarch intake as an adjunct to nutritional management in people aged eight years of age and older with glycogen storage disease type Ia. Glycogen storage disease type Ia is caused by a genetic mutation that results in a missing enzyme called glucose-6-phosphatase. This enzyme normally releases free glucose (a simple sugar and main source of energy for the body) from the liver and kidneys into the bloodstream, helping to maintain stable blood sugar levels during fasting and between meals. This enzyme deficiency causes the blood sugar to drop dangerously low whenever a person goes too long without eating. The condition can lead to long-term metabolic complications that can impair normal function in certain organs and tissues. Pariglasgene brecaparvovec is a one-time AAV8 based gene therapy designed to deliver a functional glucose-6-phosphatase gene to the liver, aiming to restore the deficient enzyme required to release stored glucose and ensure stable blood sugar levels when a person is fasting.

History The effectiveness of pariglasgene brecaparvovec was evaluated in a randomized, double-blind, placebo-controlled study in participants with GSDIa followed over 48 weeks after dosing. Participants treated with pariglasgene brecaparvovec demonstrated a statistically significant mean reduction from baseline in daily cornstarch intake of 31% compared to placebo, the study's primary endpoint. A mean reduction from baseline of one cornstarch dose per day was seen in the pariglasgene brecaparvovec group compared to placebo, the study's secondary endpoint. Pariglasgene brecaparvovec-treated participants experienced a numerical (mean 3%) increase in the percentage of glucose values in the hypoglycemic range (< 70 mg/dL) compared to placebo.

Society and culture

Legal status Pariglasgene brecaparvovec was approved for medical use in the United States in August 2026. The US Food and Drug Administration (FDA) granted the application for pariglasgene brecaparvovec regenerative medicine advanced therapy and fast track designations. The FDA granted accelerated approval of Genglycos to Ultragenyx Pharmaceutical.

Names Pariglasgene brecaparvovec is the international nonproprietary name. Pariglasgene brecaparvovec is sold under the brand name Genglycos.

References

External links Clinical trial number NCT05139316 for "A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa)" at ClinicalTrials.gov

Worked examples

Example 1 — a first encounter with Pariglasgene brecaparvovec

Start with the simplest possible case. Write down what Pariglasgene brecaparvovec claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Pariglasgene brecaparvovec before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Pariglasgene brecaparvovec ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Pariglasgene brecaparvovec

In research
Pariglasgene brecaparvovec appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Pariglasgene brecaparvovec in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Pariglasgene brecaparvovec is common in secondary-school and first-year university syllabi. It links to neighbouring topics Approved gene therapies, Drugs not assigned an ATC code, so understanding it makes those chapters shorter.
In everyday life
Look for Pariglasgene brecaparvovec outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Pariglasgene brecaparvovec” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Pariglasgene brecaparvovec in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Pariglasgene brecaparvovec means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Pariglasgene brecaparvovec out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Pariglasgene brecaparvovec in simple terms?

Pariglasgene brecaparvovec, sold under the brand name Genglycos, is a gene therapy medication used for the treatment of glycogen storage disease type Ia. Pariglasgene brecaparvovec is an adeno-associated virus vector-based gene therapy.

Why does Pariglasgene brecaparvovec matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Pariglasgene brecaparvovec?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Pariglasgene brecaparvovec.

Tags

  • Approved gene therapies
  • Drugs not assigned an ATC code

Keep exploring